Cipher Pharmaceuticals Inc. (TSX:CPH) announces a share repurchase program. Under the normal course issuer bid, the company will repurchase up to 1,337,195 units, representing 5.57% of its issued and outstanding capital. The price which company will pay for any common shares will be the market price at the time of acquisition.

The bid will be funded using company's cash resources. The repurchased shares will be cancelled. The bid will terminate on November 19, 2024.

As of November 10, 2023, the company had 24,022,338 common shares issued and outstanding.